Vitamin D Supplementation Reduces Thyroid Peroxidase Antibody Levels In Patients With Autoimmune Thyroid Disease (AITD)

Vitamin D Supplementation Reduces Thyroid Peroxidase Antibody Levels In Patients With Autoimmune Thyroid Disease (AITD): An Open-Labelled Randomized Controlled Trial is an article describing the influence of vitamin D subjoining on thyroid autoimmunity in individuals who have newly detected AITD. According to the authors, vitamin D deficiency is widely related to insulin resistance, fatty liver, cardiovascular diseases, type -2 diabetes and cancer. From the previous research, it is concluded that it also causes autoimmune disorders such as AITD. However, data on impacts of vitamin D in Thyroid Peroxidase Antibody (TPO-Abs) in people who have AITD is not sufficient, which demanded a study to address the issue. The study was conducted in a randomized controlled trial (RCT) where about 981 patients were evaluated and among them, 102 patients diagnosed with AITD gave a well-informed transcribed agreement on the matter.

Is your time best spent reading someone else’s essay? Get a 100% original essay FROM A CERTIFIED WRITER!

Save 25%

After three months of the study, the development records available was from one hundred individuals where sixty-eight of them had baseline serum TSH<10Miu/l and were grouped together as group A while the other 32 had a standard serum TSH>10m IU/L and were included in the second group. Ninety-three percent of the patients in this research had Vitamin D inadequacy. All the involved patients, on the other hand, had TPO-Ab titer>34 k IU/L and had TPO-Ab titer> 34K IU/L, which was main amongst AITD patients. After the analysis, a connection was drawn amid 25(OH) D and TPO-Ab titer especially after correcting age impending arithmetic importance. It was observed that anthropometry thyroid function and 25 (OH) D ranks were much equivalent between the two groups where group A comprised those under treatment while group B were those under control. In three months those under treatment indicated substantial fall in serum TPO-Ab titer as related to the other group. Also, it was observed that Vitamin D caused an important upturn in serum 25 (OH) D titer and a consistent reduction in plasma I-PTH intensities in the first group.

From the prior studies, vitamin D inadequacy has been related to autoimmune complaints. The authors designated that 74% occurrence of Vitamin D shortage is normal in the Eastern India population. In their analysis, the occurrence of vitamin D deficiency among individuals with AITD is about ninety-three percent, which is meaningfully advanced and is in harmony with earlier accounts in individuals with Graves disease and Hashimotos thyroiditis. Also, a current research in Korea indicated augmented occurrence of TPO-Ab positively with ultrasonography signs of AITD in premenopausal females with vitamin D insufficiency and shortage is related to those with enough Vitamin D in their bodies. In Thailand, it was observed that there was augmented occurrence of Vitamin D shortage and inadequacy amongst TPO-Ab or thyroglobulin antibody, optimistic persons, as likened to the ones with negative antibody standing.

A population-based cross-sectional study in China had not witnessed any relationship between TPO-Ab and Vitamin D condition positively. In fact, a converse relation was notable between Thyroid stimulating hormone (TSH) and 25 (OH). Also, in a research conducted at Holland prompt phases of thyroid autoimmunity were not associated with Vitamin D shortage. The above studies show how different ethnicities, disease heterogeneity, age, and changing sternness holds varying outcomes warranting for an interventional study to harmonize the issue.

From the authors study, it is evident there is a frail converse association between 25 (OH) D levels and TPO-Ab, which advanced statistical implication. The research was the major ever to validate that Vitamin D boosting in healing prescriptions is related to a momentous decrease in TPO-Ab titers in people with AITD. However, the study faced some challenges especially with the barely branded design of RCT, short follow-ups, the absence of use of placebo and valuation of the consequences mainly on TPO-Ab titers. Currently, TPO-Ab titers are the finest processes of thyroid autoimmunity in AITD. Also, decrease in TPO-Ab titers in individuals with TSH<10m IU/L and those under levothyroxine strengthen the function of Vitamin D in realizing the decrease. Therefore, the authors campaign the necessity for additional enduring imposition with Vitamin D to approximate if the decrease in TPO-Ab titers transforms into compact development of sub-clinical in the tempting reduction of hypothyroidism or clear primary hypothyroidism.

One can learn that Vitamin D insufficiency and deficiency is collective among the AITD patients, but the situation is reversible. Also, supplementation of Vitamin D among them is connected with helpful effects on autoimmunity due to reduced transmission effects of TPO-Ab titers. One also gets to understand how vitamin D decreases thyroid peroxidase antibody levels. Therefore, Vitamin D supplementation is recommendable to patients newly diagnosed with AITD. In conclusion, there is a need for a consolidated report to solve the puzzle around different findings associated with the result of Vitamin D status and AITD. Today it is evident that the connection between Vitamin D status and TPO-Ab is paramount especially to patients suffering from AITD.

References

Dutta, Deep, Samim Ali Mondal, Subhadip Choudhuri, Indira Maisnam, Abu Hena Hasanoor Reza, Basudeb Bhattacharya, Subhankar Chowdhury, and Satinath Mukhopadhyay. 2014. "Vitamin-D Supplementation in Prediabetes Reduced Progression to Type 2 Diabetes and Was Associated With Decreased Insulin Resistance and Systemic Inflammation: An Open Label Randomized Prospective Study from Eastern India". Diabetes Research and Clinical Practice 103 (3): e18-e23.

Effraimidis, G., K. Badenhoop, J. G. P. Tijssen, and W. M. Wiersinga. 2012. "Vitamin D Deficiency Is Not Associated With Early Stages Of Thyroid Autoimmunity". European Journal of Endocrinology 167 (1): 43-48.

Goswami, Ravinder, Raman Kumar Marwaha, Nandita Gupta, Nikhil Tandon, Vishnubhatla Sreenivas, Neeraj Tomar, Debarti Ray, Ratnesh Kanwar, and Rashmi Agarwal. 2009. "Prevalence of Vitamin D Deficiency and Its Relationship with Thyroid Autoimmunity in Asian Indians: A Community-Based Survey". BJN 102 (03): 382.

Jahnsen, J., J. A. Falch, P. Mowinckel, and E. Aadland. 2002. "Vitamin D Status, Parathyroid Hormone and Bone Mineral Density in Patients with Inflammatory Bowel Disease".Scandinavian Journal of Gastroenterology 37 (2): 192-199.

Zhang, Hong, Lingyun Liang, and Zhongjian Xie. 2015. "Low Vitamin D Status Is Associated With Increased Thyrotropin-Receptor Antibody Titer In Graves Disease". Endocrine Practice 21 (3): 258-263.

Zhang, Qingqing, Zhixiao Wang, Min Sun, Mengdie Cao, Zhenxin Zhu, Qi Fu, and Yuan Gao et al. 2014. "Association Of High Vitamin D Status With Low Circulating Thyroid-Stimulating Hormone Independent Of Thyroid Hormone Levels In Middle-Aged And Elderly Males". International Journal of Endocrinology 2014: 1-6.